HYDROXAMATE ALS THERAPEUTISCHE MITTEL

Patent europeic · EP1611088 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1611088
Numer da la dumonda
EP04749791
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
06-04-2004
Publitgà
04-01-2006
Concedì
17-06-2009
Stritgà
07-04-2024
Motiv
Durada maximala cuntanschida
Classas IPC
C07C 259/10 (2006.01)
Prioritad
US 461286 P 07.04.2003
US 464448 P 21.04.2003
Dumonda PCT
PCT/US2004/010549 06.04.2004
Publicaziun PCT
WO2004/092115 28.10.2004
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 07-04-2024

    Durada maximala cuntanschida

    Published in Swissreg on 07.04.2024

  2. 01-05-2023

    Midada

    Published in Swissreg on 01.05.2023

  3. 16-09-2009

    Represchentant inscrit

    Representative
    Bugnion S.A., Case postale 375, 1211 Genève 12 - Champel

    Published in Swissreg on 16.09.2009

  4. 17-06-2009

    Concedì

    Published in Swissreg on 17.06.2009

Partidas

Possessur

Pharmacyclics, Inc.

995 East Arques Avenue, Sunnyvale, CA 94086, US

Represchentant

Bugnion SA

Bugnion S.A.

Case postale 375, 1211 Genève 12 - Champel

Inventur

VERNER, Eric J.

Foster City, CA 94404, US

SENDZIK, Martin

San Mateo, CA 94403, US

BASKARAN, Chitra

Foster City, CA 94404, US

BUGGY, Joseph J.

San Carlos, CA 94070, US

ROBINSON, James

Sacramento, CA 95836, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.